180 related articles for article (PubMed ID: 33984497)
1. Platelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in Systemic Lupus Erythematosus.
Gartshteyn Y; Mor A; Shimbo D; Khalili L; Kapoor T; Geraldino-Pardilla L; Alexander RV; Conklin J; Dervieux T; Askanase AD
Clin Immunol; 2021 Jul; 228():108755. PubMed ID: 33984497
[TBL] [Abstract][Full Text] [Related]
2. Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus.
Svenungsson E; Gustafsson JT; Grosso G; Rossides M; Gunnarsson I; Jensen-Urstad K; Larsson A; Ekdahl KN; Nilsson B; Bengtsson AA; Lood C
Rheumatology (Oxford); 2020 Nov; 59(11):3264-3274. PubMed ID: 32259250
[TBL] [Abstract][Full Text] [Related]
3. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.
Lonati PA; Scavone M; Gerosa M; Borghi MO; Pregnolato F; Curreli D; Podda G; Femia EA; Barcellini W; Cattaneo M; Tedesco F; Meroni PL
Front Immunol; 2019; 10():773. PubMed ID: 31031764
[TBL] [Abstract][Full Text] [Related]
4. Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus.
Gartshteyn Y; Conklin J; Petri MA; Kyttaris VC; Goldman DW; Kammesheidt A; Askanase AD; Alexander RV
Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2088-2095. PubMed ID: 36807703
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
Lood C; Tydén H; Gullstrand B; Sturfelt G; Jönsen A; Truedsson L; Bengtsson AA
PLoS One; 2014; 9(6):e99386. PubMed ID: 24922069
[TBL] [Abstract][Full Text] [Related]
6. Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies.
Peerschke EI; Yin W; Alpert DR; Roubey RA; Salmon JE; Ghebrehiwet B
Lupus; 2009 May; 18(6):530-8. PubMed ID: 19395455
[TBL] [Abstract][Full Text] [Related]
7. A Review of Complement Activation in SLE.
Weinstein A; Alexander RV; Zack DJ
Curr Rheumatol Rep; 2021 Feb; 23(3):16. PubMed ID: 33569681
[TBL] [Abstract][Full Text] [Related]
8. In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation.
Andrianova IA; Ponomareva AA; Mordakhanova ER; Le Minh G; Daminova AG; Nevzorova TA; Rauova L; Litvinov RI; Weisel JW
J Autoimmun; 2020 Feb; 107():102355. PubMed ID: 31732191
[TBL] [Abstract][Full Text] [Related]
9. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d.
Sciascia S; Bloch R; O'Malley T; Kammesheidt A; Alexander RV
Front Immunol; 2022; 13():949919. PubMed ID: 36032074
[TBL] [Abstract][Full Text] [Related]
11. Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.
Ramsey-Goldman R; Alexander RV; Massarotti EM; Wallace DJ; Narain S; Arriens C; Collins CE; Saxena A; Putterman C; Kalunian KC; O'Malley T; Dervieux T; Weinstein A
Arthritis Rheumatol; 2020 Jan; 72(1):78-88. PubMed ID: 31469249
[TBL] [Abstract][Full Text] [Related]
12. SLE: mechanisms of vascular injury.
Abramson SB; Belmont HM
Hosp Pract (1995); 1998 Apr; 33(4):107-10, 113-4, 119-22 passim. PubMed ID: 9562836
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
14. Complement activation on platelets: implications for vascular inflammation and thrombosis.
Peerschke EI; Yin W; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2170-5. PubMed ID: 20621693
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
Kalunian KC; Chatham WW; Massarotti EM; Reyes-Thomas J; Harris C; Furie RA; Chitkara P; Putterman C; Gross RL; Somers EC; Kirou KA; Ramsey-Goldman R; Hsieh C; Buyon JP; Dervieux T; Weinstein A
Arthritis Rheum; 2012 Dec; 64(12):4040-7. PubMed ID: 22932861
[TBL] [Abstract][Full Text] [Related]
16. Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE.
Petri MA; Conklin J; O'Malley T; Dervieux T
Lupus Sci Med; 2019; 6(1):e000318. PubMed ID: 31168401
[TBL] [Abstract][Full Text] [Related]
17. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
Front Immunol; 2019; 10():885. PubMed ID: 31134052
[TBL] [Abstract][Full Text] [Related]
18. FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus.
Melki I; Allaeys I; Tessandier N; Mailhot B; Cloutier N; Campbell RA; Rowley JW; Salem D; Zufferey A; Laroche A; Lévesque T; Patey N; Rauch J; Lood C; Droit A; McKenzie SE; Machlus KR; Rondina MT; Lacroix S; Fortin PR; Boilard E
Blood; 2020 Dec; 136(25):2933-2945. PubMed ID: 33331924
[TBL] [Abstract][Full Text] [Related]
19. Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus: covariation with platelet activation and possible association with thrombosis.
Ekdahl KN; Rönnblom L; Sturfelt G; Nilsson B
Arthritis Rheum; 1997 Dec; 40(12):2178-86. PubMed ID: 9416855
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet aggregation by an SLE-derived human hybridoma autoantibody against an activation-dependent antigen.
Xu H; Frojmovic MM; Wong T; Rauch J
Thromb Haemost; 1995 Oct; 74(4):1152-62. PubMed ID: 8560428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
